who qualifies for glp-1 drugs MCT2D Chart: 1 in 8 Americans
Description
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective for glycaemic control and weight loss in patients with type 2 diabetes (T2D)
I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance)
Easy once-a-day use
However, no direct link has been found between GLP-1R agonists and higher pulmonary aspiration risk
88% reduced sugar cravings
